Clinical Implications of the European Myocardial Infarct Amiodarone Trial (EMIAT)
Tóm tắt
Từ khóa
Tài liệu tham khảo
Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encanide, fleccanide or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;324:781-787.
The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the anti-arrhythmic agent moricizinc on survival after myocardial infarction. N Engl J Med 1992;327:227-233.
Bigger JT Jr, Flaiss JL, Kleiger J, et al. The relationship among ventricular arrhythmias, left ventricular dysfunction, and mortality in two years after myocardial infarction. Circulation 1984;69:250-258.
Cairns JA, Connolly SJ, Roberts R, Gent M, for the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet 1997;349:675-682.
Amiodarone Trials Meta-analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive cardiac failure, meta-analysis of individual data from 6,500 patients in randomised trials. Lancet 1997;350:1417-24.